Covista Inc. (CVSA)
Official siteCONSUMER DEFENSIVE • EDUCATION & TRAINING SERVICES • NYSE
Market Cap: $3.93B
Last updated: Nov 17, 2026 at 11:03 AM ET
Covista Inc. (CVSA) Earnings: Report Dates and Results
Covista (CVSA) is expected to report earnings on Jan 26, 2027. In the quarter ended Sep 30, 2026, Covista reported EPS of $2.19, above the $1.90 estimate. It beat the EPS estimate in each of the last 19 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CVSA has an expected report date of Jan 26, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 10.3% below the $2.43 reported for the quarter ended Dec 31, 2025.
CVSA Earnings Call
The latest CVSA earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, CVSA beat 31, missed 6 and matched 3. Revenue for the quarter ended Sep 30, 2026 was $511.53M, up 10.7% from $462.29M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $2.19 | $1.90 | $1.78 - $1.90 | +15.26% | Beat | +25.1% | 4 | 1 up, 0 down | Oct 29, 2026 | $511.53M |
| Jun 30, 2026 | $2.09 | $1.90 | $1.83 - $1.93 | +10.00% | Beat | +25.9% | 4 | 0 up, 1 down | Aug 6, 2026 | $501.38M |
| Mar 31, 2026 | $1.98 | $1.72 | $1.63 - $1.85 | +15.12% | Beat | +3.1% | 4 | 0 up, 3 down | May 7, 2026 | $487.03M |
| Dec 31, 2025 | $2.43 | $2.19 | $2.12 - $2.29 | +10.96% | Beat | +34.3% | 4 | 1 up, 0 down | Jan 28, 2026 | $503.38M |
| Sep 30, 2025 | $1.75 | $1.58 | $1.54 - $1.60 | +10.76% | Beat | +35.7% | 4 | 1 up, 0 down | Oct 30, 2025 | $462.29M |
| Jun 30, 2025 | $1.66 | $1.51 | $1.49 - $1.55 | +9.93% | Beat | +21.2% | 4 | N/A | Aug 7, 2025 | $457.11M |
| Mar 31, 2025 | $1.92 | $1.65 | $1.62 - $1.68 | +16.36% | Beat | +28.0% | 4 | 0 up, 2 down | May 8, 2025 | $466.06M |
| Dec 31, 2024 | $1.81 | $1.37 | $1.33 - $1.40 | +32.12% | Beat | +47.2% | 3 | 1 up, 1 down | Jan 30, 2025 | $447.73M |
| Sep 30, 2024 | $1.29 | $1.13 | $1.12 - $1.15 | +14.16% | Beat | +38.7% | 2 | 0 up, 0 down | Oct 29, 2024 | $417.40M |
| Jun 30, 2024 | $1.37 | $1.28 | $1.24 - $1.31 | +7.03% | Beat | +33.0% | 3 | 0 up, 0 down | Aug 6, 2024 | $409.91M |
| Mar 31, 2024 | $1.50 | $1.16 | $1.14 - $1.19 | +29.31% | Beat | +32.7% | 3 | 0 up, 0 down | May 2, 2024 | $412.66M |
| Dec 31, 2023 | $1.23 | $0.98 | $0.94 - $1.01 | +25.51% | Beat | +5.1% | 3 | 0 up, 0 down | Jan 30, 2024 | $393.24M |
| Sep 30, 2023 | $0.93 | $0.80 | $0.78 - $0.82 | +16.25% | Beat | +5.7% | 3 | 0 up, 0 down | Oct 26, 2023 | $368.85M |
| Jun 30, 2023 | $1.03 | $0.97 | $0.95 - $1.00 | +6.19% | Beat | -21.4% | 3 | 0 up, 0 down | Aug 10, 2023 | $364.64M |
| Mar 31, 2023 | $1.13 | $0.91 | $0.91 - $0.92 | +24.18% | Beat | +29.9% | 3 | 0 up, 0 down | May 2, 2023 | $369.08M |
| Dec 31, 2022 | $1.17 | $0.88 | $0.88 - $0.89 | +32.95% | Beat | +56.0% | 3 | 0 up, 0 down | Mar 31, 2023 | $362.83M |
| Sep 30, 2022 | $0.88 | $0.75 | $0.62 - $0.93 | +17.33% | Beat | +41.9% | 3 | 0 up, 0 down | Nov 3, 2022 | $354.27M |
| Jun 30, 2022 | $1.31 | $1.25 | $1.23 - $1.28 | +4.80% | Beat | +87.1% | 3 | 0 up, 0 down | Aug 11, 2022 | $357.29M |
| Mar 31, 2022 | $0.87 | $0.82 | $0.78 - $0.88 | +6.10% | Beat | +20.8% | 3 | 0 up, 0 down | May 5, 2022 | $364.28M |
| Dec 31, 2021 | $0.75 | $0.96 | $0.90 - $1.00 | -21.88% | Miss | -2.6% | 3 | N/A | Mar 31, 2022 | $371.20M |
| Sep 30, 2021 | $0.62 | $0.74 | $0.72 - $0.75 | -16.22% | Miss | -20.5% | 3 | 0 up, 0 down | Nov 3, 2021 | $289.07M |
| Jun 30, 2021 | $0.70 | $0.70 | $0.69 - $0.71 | 0.00% | In line | +20.7% | 3 | N/A | Aug 19, 2021 | $166.40M |
| Mar 31, 2021 | $0.72 | $0.69 | $0.68 - $0.70 | +4.35% | Beat | -11.1% | 3 | N/A | Apr 29, 2021 | $230.21M |
| Dec 31, 2020 | $0.77 | $0.67 | $0.65 - $0.69 | +14.93% | Beat | +35.1% | 3 | N/A | Mar 31, 2021 | $234.40M |
| Sep 30, 2020 | $0.78 | $0.38 | $0.35 - $0.47 | +105.26% | Beat | +129.4% | 3 | N/A | Nov 5, 2020 | $268.24M |
| Jun 30, 2020 | $0.58 | $0.64 | $0.60 - $0.74 | -9.38% | Miss | -40.2% | 4 | N/A | Aug 18, 2020 | $74.16M |
| Mar 31, 2020 | $0.81 | $0.67 | $0.65 - $0.68 | +20.90% | Beat | +19.1% | 4 | N/A | May 5, 2020 | $271.49M |
| Dec 31, 2019 | $0.57 | $0.55 | $0.53 - $0.58 | +3.64% | Beat | -23.0% | 4 | N/A | Feb 4, 2020 | $266.17M |
| Sep 30, 2019 | $0.34 | $0.46 | $0.45 - $0.47 | -26.09% | Miss | -24.4% | 5 | N/A | Oct 29, 2019 | $254.61M |
| Jun 30, 2019 | $0.97 | $0.96 | $0.95 - $0.97 | +1.04% | Beat | +12.8% | 4 | N/A | Aug 22, 2019 | $264.24M |
| Mar 31, 2019 | $0.68 | $0.65 | $0.64 - $0.66 | +4.62% | Beat | -5.6% | 5 | N/A | May 2, 2019 | $258.70M |
| Dec 31, 2018 | $0.74 | $0.74 | $0.71 - $0.77 | 0.00% | In line | -2.6% | 4 | N/A | Mar 31, 2019 | $253.96M |
| Sep 30, 2018 | $0.45 | $0.41 | $0.37 - $0.62 | +9.76% | Beat | +50.0% | 6 | N/A | Nov 1, 2018 | $236.94M |
| Jun 30, 2018 | $0.86 | $0.91 | $0.87 - $0.93 | -5.49% | Miss | +10.3% | 6 | N/A | Aug 16, 2018 | $48.85M |
| Mar 31, 2018 | $0.72 | $0.71 | $0.70 - $0.72 | +1.41% | Beat | +2.9% | 5 | N/A | May 3, 2018 | $310.07M |
| Dec 31, 2017 | $0.76 | $0.76 | $0.71 - $0.79 | 0.00% | In line | -10.6% | 5 | N/A | Mar 31, 2018 | $308.21M |
| Sep 30, 2017 | $0.30 | $0.46 | N/A | -34.78% | Miss | -33.3% | N/A | N/A | Nov 2, 2017 | $293.14M |
| Jun 30, 2017 | $0.78 | $0.70 | N/A | +11.43% | Beat | +20.0% | N/A | N/A | Aug 17, 2017 | $91.38M |
| Mar 31, 2017 | $0.70 | $0.65 | N/A | +7.69% | Beat | -1.4% | N/A | N/A | May 4, 2017 | $332.68M |
| Dec 31, 2016 | $0.85 | $0.73 | N/A | +16.44% | Beat | +25.0% | N/A | N/A | Mar 31, 2017 | $333.96M |
Annual EPS
EPS for the fiscal year ended Jun 30, 2026 was $8.25, up 23.5% from the year before. It was $2.78 for the year ended Jun 30, 2017, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Jun 30, 2026 | $8.25 | +23.5% |
| Jun 30, 2025 | $6.68 | +32.8% |
| Jun 30, 2024 | $5.03 | +19.5% |
| Jun 30, 2023 | $4.21 | +18.6% |
| Jun 30, 2022 | $3.55 | +19.5% |
| Jun 30, 2021 | $2.97 | +29.1% |
| Jun 30, 2020 | $2.30 | -19.0% |
| Jun 30, 2019 | $2.84 | +7.6% |
| Jun 30, 2018 | $2.64 | -5.0% |
| Jun 30, 2017 | $2.78 | N/A |
Earnings Calls
The 5 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 4,500 words across 7 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 4,507 | 7 | |
| 2026Q2 | Jun 30, 2026 | 4,040 | 6 | |
| 2026Q1 | Mar 31, 2026 | 5,428 | 8 | |
| 2025Q4 | Dec 31, 2025 | 4,510 | 7 | |
| 2025Q3 | Sep 30, 2025 | 3,970 | 8 |
2026Q3 Earnings Call
Opening remarks
Jeremy Cohen Vice President, Investor Relations Good afternoon, and welcome to Covista's Earnings Call for the Fiscal Year 2026 Third Quarter Results. On the call with me today are Steve Beard, Chairman and Chief Executive Officer of Covista; and Bob Phelan, Chief Financial Officer. Before I hand you over to Steve, I will take you through the legal safe harbor and cautionary declarations. Certain statements and projections of future results made in this presentation constitute forward-looking statements that are based on our current market, competitive and regulatory expectations and are subject to risks and uncertainties that could cause actual results to vary materially. We undertake no obligation to update publicly any forward-looking statement after this presentation, whether as a result of new information, future events, changes in assumptions or otherwise. Please see our latest Form 10-K and Form 10-Q for a discussion of risk factors as they relate to forward-looking statements. In today's presentation, we will use certain non-GAAP financial measures. And we refer you to the appendix in the presentation materials available on our Investor Relations website for reconciliations to the most directly comparable GAAP financial measures and related information. You will find a link to the webcast on our Investor Relations website at investors.covista.com. After this call, the presentation and webcast will be archived on the website for 30 days. I will now hand you over to Steve.
Stephen Beard Chairman and Chief Executive Officer Thanks, Jeremy. Good afternoon, everyone, and thank you for joining us. This is our first earnings call as Covista. The name reflects what we've been building, a single platform for health care workforce development on a national scale, backed by the performance you're seeing in this quarter's results. The structural backdrop for our business hasn't changed and remains highly durable. There are roughly 700,000 health care jobs posted every month in the U.S. and only 306,000 unemployed health care workers to fill them. That's a patient care problem, not a staffing problem, and it's exactly what we were built to solve. 5 institutions, more than 24,000 health care graduates a year, deep clinical relationships and a footprint that reaches communities most under strain. And we're increasingly connecting our market-leading capacity to produce health care workers directly to employers through programs that fund education, deliver clinical experience and create hiring pathways. No one else does this at our scale. Three things defined this quarter. First, we surpassed 100,000 students, achieved our 11th consecutive quarter of total enrollment growth and delivered record enrollment at both Chamberlain and Walden. Second, Chamberlain returned to positive total enrollment growth ahead of our expectations. The operating changes that we committed to are, in fact, working.
Frequently Asked Questions About CVSA
When is Covista's next earnings date?
Covista's next earnings report is expected for Jan 26, 2027.
Did CVSA beat earnings estimates last quarter?
Yes. Covista reported EPS of $2.19 for the quarter ended Sep 30, 2026, above the $1.90 estimate, a 15.26% surprise.
What EPS do analysts expect from CVSA next quarter?
The consensus EPS estimate for Covista for the quarter ending Dec 31, 2026 is $2.18 from 4 analysts, with estimates from $2.05 to $2.29.
How often does CVSA beat earnings estimates?
Covista beat the EPS estimate in each of the last 19 quarters, with an average surprise of +16.02%.
CVSA pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors